SCHEMBL9906265

SCHEMBL9906265

O=C(CCSC(C(=O)NCCOCCOCCNC(=O)c1ccc(-c2c3ccc(=O)cc-3oc3cc(O)ccc23)c(C(=O)O)c1)c1ccccc1)ON1C(=O)CCC1=O

nearest known ligand 0.51

Predicted protein targets (top 14)

geneUniProtsupporting neighboursconfidence
▸ FOLH1 Q04609 2/20 0.51
▸ HTR3A P46098 2/20 0.43
▸ BTK Q06187 1/20 0.43
▸ ALB P02768 1/20 0.43
▸ CA9 Q16790 2/20 0.41
▸ ESR1 P03372 1/20 0.41
▸ USP2 O75604 1/20 0.41
▸ L3MBTL1 Q9Y468 1/20 0.41
▸ SLC5A2 P31639 3/20 0.41
▸ HTRA2 O43464 2/20 0.41
▸ HTRA1 Q92743 2/20 0.41
▸ CA12 O43570 1/20 0.40
▸ CA1 P00915 1/20 0.40
▸ CA2 P00918 1/20 0.40

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL9906147 0.96 FOLH1 (0.46) FOLH1ALBCA9ESR1USP2
SCHEMBL13780483 0.93 FOLH1 (0.44) FOLH1HTR3ABTKHTRA2HTRA1
SCHEMBL9906219 0.91 FOLH1 (0.49) FOLH1ALBCA9ESR1USP2
SCHEMBL14402386 0.90 FOLH1 (0.50) FOLH1ALBSLC5A2HTRA2HTRA1
SCHEMBL14426888 0.89 HTRA2 (0.41) FOLH1ALBUSP2HTRA2HTRA1
SCHEMBL9906326 0.87 FOLH1 (0.56) FOLH1HTR3ABTKALBCA9
SCHEMBL14426890 0.84 HTRA2 (0.43) FOLH1ALBHTRA2HTRA1
SCHEMBL14402764 0.84 FOLH1 (0.50) FOLH1HTR3ABTKALBESR1
SCHEMBL9906327 0.83 FOLH1 (0.52) FOLH1ALBCA9ESR1USP2
SCHEMBL9906229 0.83 FOLH1 (0.51) FOLH1BTKALBESR1USP2

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 8 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-1673399-B1 DETECTING AND PROFILING MOLECULAR COMPLEXES MONOGRAM BIOSCIENCES INC (US) 2017-04-05 — — EP disclosed
US-8198031-B2 Using epidermal growth factor receptor complexes to diagnose and prognose health in cancer patients; drug screening MONOGRAM BIOSCIENCES, INC. (US) 2012-06-12 — — US disclosed
EP-1540347-B1 DETECTING RECEPTOR OLIGOMERIZATION ACLARA BIOSCIENCES INC (US) 2009-09-09 — — EP disclosed
US-20090011432-A1 Detecting and Profiling Molecular Complexes MONOGRAM BIOSCIENCES, INC. (US) 2009-01-08 — — US disclosed
US-20080233602-A1 Detecting and profiling molecular complexes MONOGRAM BIOSCIENCES, INC. 2008-09-25 — — US disclosed
US-7402397-B2 Detecting and profiling molecular complexes MONOGRAM BIOSCIENCES, INC. (US) 2008-07-22 — — US disclosed
US-7255999-B2 Detection of preferential polypetide in sample; otain sample containing preferential polyeptide, electrophorese, incubate with probe, detect signal from probe and recover polypeptide MONOGRAM BIOSCIENCES, INC. (US) 2007-08-14 — — US disclosed
US-7160735-B2 Tagged microparticle compositions and methods MONOGRAM BIOSCIENCES, INC. (US) 2007-01-09 — — US disclosed
Send feedback